Table 1.
Demographics of participants
Values | |
---|---|
Age (years) |
38 (19) |
Female (%) |
62 |
Daily dose at week 4 (max) (mg) |
103 (38) |
DUP (months) |
2.1 (0.9) |
HAMD17 (baseline) | 19.3 (2.8) |
Demographics of participants
Values | |
---|---|
Age (years) |
38 (19) |
Female (%) |
62 |
Daily dose at week 4 (max) (mg) |
103 (38) |
DUP (months) |
2.1 (0.9) |
HAMD17 (baseline) | 19.3 (2.8) |